Investors / Star51 Capital
Star51 Capital
Venture capital
Star51 Capital is a venture firm that invests in the convergence of Medtech and AI. It is operator-led, backing founders and management teams with the aim of building companies toward acquisition.
Invests inHealthcare & Biotech
In its own wordsmedtechaihealthcarephysical aimedical imaging
Your fit with Star51 Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsStar51 Capital lists 16 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Growth, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (94%) and Robotics & Hardware (6%). 91% of its companies are based in United States. It invests most often alongside Endeavour Vision, Intuitive Ventures and Longitude Capital.
Counts come from funding rounds that name Star51 Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Star51 Capital's whole history. Rounds on record name 1 company; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 100% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 39th | 15 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 69th | 7% of companies confirmed by a round |
| Sector focus | 96th | 94% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Endeavour Vision | 2 |
| Intuitive Ventures | 2 |
| Longitude Capital | 2 |
| Santé Ventures | 2 |
| Yu Galaxy | 2 |
| ALIVE Israel HealthTech Fund | 1 |
| Advent Life Sciences | 1 |
| Agoranov | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers16100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 94% | 15% |
| Robotics & Hardware | 6% | 1% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Endeavour Vision
Compare Star51 Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Star51 Capital| Date | Company | Stage |
|---|---|---|
| 22 Sept 2026 | Series C+ |
Round details for Star51 Capital
Amounts, full round histories and every co-investor in Star51 Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding nitinol scaffold to improve lung function and breathing capacity. | Healthcare & Biotech | Portfolio page | ||
| Axon Therapies develops and offers a treatment for heart failure using a minimally invasive procedure called SAVM. | Healthcare & Biotech | Portfolio page | ||
| Capstan Medical develops and provides a less invasive treatment for heart valve disease using surgical robotics and catheter-based technology. | Healthcare & Biotech | Portfolio page | ||
| CLARO Surgical uses Spatial AI for orthopaedic trauma | Healthcare & Biotech | Portfolio page | ||
| Deerfield Catalyst combines the resources of two established healthcare pioneers and is a medtech incubator | Healthcare & Biotech | Portfolio page | ||
| Epitel develops and provides a remote EEG monitoring system called REMI | Healthcare & Biotech | Portfolio page | ||
| Kestra Medical Technologies provides medical technologies for providers. | Healthcare & Biotech | Portfolio page | ||
| Leo Cancer Care develops and provides radiation therapy solutions, including particle and photon therapy, with a focus on upright patient positioning | Healthcare & Biotech | Portfolio page | ||
| Microbot Medical develops and sells a robotic system for endovascular procedures. | Healthcare & Biotech | Portfolio page | ||
| Moon Surgical develops and markets a robotic system for surgical assistance | Healthcare & Biotech | Portfolio page | ||
| Nalu provides instructions and support for its neurostimulation system | Healthcare & Biotech | Portfolio page | ||
| Oath provides patients with access to high quality, lower cost surgical care in outpatient settings | Healthcare & Biotech | Portfolio page | ||
| The company develops a blood purification therapy to treat sepsis by removing bacteria from the bloodstream. | Healthcare & Biotech | Portfolio page | ||
| Sinaptica Therapeutics has developed a personalized closed-loop neuromodulation therapy for Alzheimer's Disease | Healthcare & Biotech | Portfolio page | ||
| UltraSight is an AI-powered cardiac workflow company advancing access to high-quality cardiac ultrasound. | Healthcare & Biotech | Sept 2026Series C+ | Page + round | |
| VitVio develops and provides 3D spatial intelligence technology for automating surgical environments | Healthcare & BiotechRobotics & Hardware | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- star51capital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 22 Sept 2026
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Star51 Capital's profile as data
Pull Star51 Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/star51capital.com
# also
GET /v1/firms/star51capital.com/portfolio
GET /v1/firms/star51capital.com/coinvestors
GET /v1/firms/star51capital.com/news